These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37634619)

  • 21. Risk factors for post-coronavirus disease condition in the Alpha-, Delta-, and Omicron-dominant waves among adults in Japan: A population-based matched case-control study.
    Hori M; Hayama-Terada M; Kitamura A; Hosozawa M; Muto Y; Iba A; Takayama Y; Kimura T; Iso H
    J Med Virol; 2024 Sep; 96(9):e29928. PubMed ID: 39311094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between vaccination status and COVID-19-related health outcomes among community-dwelling COVID-19 patients in Nara, Japan.
    Tomioka K; Uno K; Yamada M
    Environ Health Prev Med; 2023; 28():7. PubMed ID: 36682815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China.
    Yin Z; Fang Q; Wen T; Zheng C; Fu C; Wang S; Li J; Gong X
    Hum Vaccin Immunother; 2023 Dec; 19(1):2163813. PubMed ID: 36704960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 Study.
    Bai F; Santoro A; Hedberg P; Tavelli A; De Benedittis S; de Morais Caporali JF; Marinho CC; Leite AS; Santoro MM; Ceccherini Silberstein F; Iannetta M; Juozapaité D; Strumiliene E; Almeida A; Toscano C; Ruiz-Quiñones JA; Mommo C; Fanti I; Incardona F; Cozzi-Lepri A; Marchetti G;
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age.
    Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM
    JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
    COVID-19 Forecasting Team
    Lancet; 2023 Mar; 401(10379):833-842. PubMed ID: 36930674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022).
    Petrone D; Mateo-Urdiales A; Sacco C; Riccardo F; Bella A; Ambrosio L; Lo Presti A; Di Martino A; Ceccarelli E; Del Manso M; Fabiani M; Stefanelli P; Pezzotti P; Palamara A;
    Int J Infect Dis; 2023 Apr; 129():135-141. PubMed ID: 36708869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain.
    López-Muñoz I; Torrella A; Pérez-Quílez O; Castillo-Zuza A; Martró E; Bordoy AE; Saludes V; Blanco I; Soldevila L; Estrada O; Valerio L; Roure S; Vallès X
    Emerg Infect Dis; 2022 Oct; 28(10):1999-2008. PubMed ID: 36037811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.
    Bormann M; Brochhagen L; Alt M; Otte M; Thümmler L; van de Sand L; Kraiselburd I; Thomas A; Gosch J; Braß P; Ciesek S; Widera M; Dolff S; Dittmer U; Witzke O; Meyer F; Lindemann M; Schönfeld A; Rohn H; Krawczyk A
    Front Immunol; 2023; 14():1150667. PubMed ID: 37520539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance.
    Bozio CH; Butterfield KA; Briggs Hagen M; Grannis S; Drawz P; Hartmann E; Ong TC; Fireman B; Natarajan K; Dascomb K; Gaglani M; DeSilva MB; Yang DH; Midgley CM; Dixon BE; Naleway AL; Grisel N; Liao IC; Reese SE; Fadel WF; Irving SA; Lewis N; Arndorfer J; Murthy K; Riddles J; Valvi NR; Mamawala M; Embi PJ; Thompson MG; Stenehjem E
    J Infect Dis; 2023 Jun; 227(12):1348-1363. PubMed ID: 36806690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
    Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK
    PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
    Ma J; Liu X; Zhou M; Chen P; Chen R; Wang J; Zhu H; Wu K; Ye J; Zhang Y; Yuan Q; Tang Q; Yuan L; Cheng T; Guan Y; Xia N
    J Virol; 2023 Feb; 97(2):e0168422. PubMed ID: 36651747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study.
    Morello R; Mariani F; Mastrantoni L; De Rose C; Zampino G; Munblit D; Sigfrid L; Valentini P; Buonsenso D
    EClinicalMedicine; 2023 May; 59():101961. PubMed ID: 37073325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory Biomarkers Differ among Hospitalized Veterans Infected with Alpha, Delta, and Omicron SARS-CoV-2 Variants.
    Park C; Tavakoli-Tabasi S; Sharafkhaneh A; Seligman BJ; Hicken B; Amos CI; Chou A; Razjouyan J
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-COVID-19 Condition After SARS-CoV-2 Infections During the Omicron Surge vs the Delta, Alpha, and Wild Type Periods in Stockholm, Sweden.
    Hedberg P; Nauclér P
    J Infect Dis; 2024 Jan; 229(1):133-136. PubMed ID: 37665981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022.
    Andeweg SP; de Gier B; Vennema H; van Walle I; van Maarseveen N; Kusters NE; de Melker HE; Hahné SJ; van den Hof S; Eggink D; Knol MJ
    Euro Surveill; 2023 Feb; 28(7):. PubMed ID: 36795499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study.
    Corrao G; Franchi M; Rea F; Cereda D; Barone A; Borriello CR; Della Valle PG; Ercolanoni M; Fortino I; Jara J; Leoni O; Mazziotta F; Pierini E; Preziosi G; Tirani M; Galli M; Bertolaso G; Pavesi G; Bortolan F
    BMC Med; 2022 Feb; 20(1):52. PubMed ID: 35130877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.